Exacerbated chronic obstructive pulmonary disease: current trends in diagnosis and treatment (review)


Cite item

Full Text

About the authors

S N Avdeev

References

  1. Global Initiative for Chronic Obstructive Lung Diseas (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO workshop report. Publication Number 2701, April 2001: 1-100. The 2003 report is available on www.goldcopd.com <http://www.goldcopd.com>
  2. Zielinski I., MacNee W., Wedzicha J. et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis. 1997; 52: 43-47.
  3. Georgupolos D., Antonisen N. R. Symptoms and signs of COPD. In: Cherniak N. S., ed. Chronic obstructive pulmonary disease. Philadelphia: Saunders; 1991. 357-363.
  4. Rodriguez-Raisin R. Toward a consensus definition for COPD exacerbation. Chest 2000; 117: 398S-401S.
  5. Burge S., Wedzicha J. A. COPD exacerbations: definitions and classifications. Eur. Respir. JL 2003; 21(suppl. 41): 46s-53s.
  6. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108: 43S-52S.
  7. Siafakas N. M., Vermeire P., Pride N. B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J. 1995; 8: 1398-1420.
  8. Fagon J. Y., Chastre J., Trouillet J. L. et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis: use of the protected specimen brush technique in 54 mechanically ventilated patients. Am. Rev. Respir. Dis. 1990; 142: 1004-1008.
  9. Soler N., Torres A., Ewig S. et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am. J. Respir. Crit. Care Med. 1998; 157: 1498-1505.
  10. Mogulkoc N., Karakurt S., Isalska B. et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am. J. Respir. Crit. Care Med. 1999; 160: 349-353.
  11. Blasi F., Legnani D., Lombardo V. M. et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur. Respir. J. 1993; 6: 19-22.
  12. Seemungal Т., Donaldson G. C., Breuer J. et al. Rhinoviruses are associated with Seemungal Т., Donaldson G. C, Breuer J. et a exacerbations of COPD. Eur. Respir. J. 1998; 12 (suppl. 28): 298 s.
  13. Anderson H. R., Spix C., Medicna S. et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur. Respir. J. 1998; 11: 992-993.
  14. Sunyer J., Saez M., Murillo С. et al. Air pollution and emeraency room admission for chronic obstructive pulmonary disease: a 5-year study. Am. J. Epidemiol. 1993; 137: 701-705.
  15. Mahler D. A. Assessment of and relief of dyspnoea. Monaldi Arch.Chest Dis. 1998; 53: 466-470.
  16. О Donnell D. E., Webb K. A. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am. Rev. Respir. Dis. 1993; 148: 135L-1357.
  17. О 'Donnell D. E., Bertley J. C., Chau L. K. L. et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiological mechanisms. Am. J. Respir. Crit. Care Med. 1997; 155: 109-115.
  18. Stockley R. A., O'Brien C., Pye A., Hill S. E. Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest 2000; 117: 1638-1645.
  19. Siaitre В., Similowski Т., Derenne J.-P. Physical examination of the adult patient with respiratory diseases: inspection and palpation. Eur. Respir. J. 1995; 8: 1584-1593.
  20. S'inane V., Rypens F., Yernault J.-C., De Troyer A. Abdominal muscle use during breathing in patients with chronic airflow obstruction. Am. Rev. Respir. Dis. 1992; 146: 16-21.
  21. Cohen С. A., Zagelbaum G., Gross D. et al. Clinical manifestation of inspiratory muscle fatigue. Am. J. Med. 1982; 73: 308- 316.
  22. Derenne J.-P., Fleury В., Pariente R. Acute respiratory failure of chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1988; 138: 1006-1033.
  23. Stoller J. K., Wiedemann H. P. Chronic obstructive lung disease: asthma, emphysema, chronic bronchitis, bronchoectasis, and related conditions. In: George R. B. et al., (eds). Chest medicine. Essentials of pulmonary and critical care medicine. Baltimore: Williams & Wilkins; 1990: 161-208.
  24. Matthay M. A., Hopewell P. С. Acute respiratory failure. In:George R. B. et al. (eds). Chest medicine. Essentials of pulmonary and critical care medicine. Baltimore: Williams & Wilkins, 1990. 413-437.
  25. Vitacca M., Clini E., Porta R. et al. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. Eur. Respir. J. 1996; 9: 1487-1493.
  26. Jeffrey A. A., Warren P. M., Flenley D. C. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax 1992; 47: 34-40.
  27. Connors A. F. Jr., Dawson N. V., Thomas С. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 1996; 154: 959-967.
  28. Friedman M. Changing practices in COPD. A new pharmacologic treatment algorithm. Chest 1995; 107 (suppl. 5): 194S- 197S.
  29. Scorodin M. S. Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Arch. Intern. Med. 1993; 153: 814-828.
  30. Siefkin A. D. Optimal pharmacologic treatment of the critically ill patients with obstructive airways disease. Am. J. Med. 1996; 100 (suppl. 1A): 54S-61S.
  31. Karpel J. P., Pesin J., Greenberg D., Gentry E. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest. 1990; 98: 835-839.
  32. Backman R., Hellstrom P. E. Fenoterol and ipratropium bromide for treatment of patients with chronic bronchitis. Curr. Ther. Res. 1985; 38: 135-140.
  33. Rebuck A. S., Chapman K. R., Abboud R. et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.Am. J. Med. 1987; 82: 59-64.
  34. Shrestha M., O'Brien Т., Haddox R. et al. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy. Ann. Emerg. Med. 1991; 20: 1206-1209.
  35. Fernandez A., Munoz J., de la Calle B. et al. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med. 1994; 20: 199-202.
  36. Seidenfeld J. J., Jones W. N., Moss R. E. et al. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease. Ann. Emerg. Med. J. 1984; 13: 248-252.
  37. Rice K. L., Leatherman J. W., Duane P. G. et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. Ann. Intern. Med. 1987; 107: 305- 309.
  38. Barr R. G., Rowe B. H., Camargo С. A. Methylxanthines for exacerbations of chronic obstructive pulmonary disease. (Cochrane Review). In: Cochrane Library. Oxford: Update Software; 2003; issue 3.
  39. Wilkens H., Sybrecht G. W. The role of bronchoconstriction during acute respiratory failure of chronic obstructive pulmonary disease. Bronchodilators and corticosteroids. In: Derenne J.-P., Whitelaw W. A., Similowski Т., eds. Acute respiratory failure in chronic obstructive pulmonary disease. New York: Marcel Dekker Inc.; 1995. 489-509.
  40. Turner M. O., Patel A., Ginsburg S., Fitzgerald J. M. Bronchodilator delivery in acute airflow obstruction: a meta-analy- sis. Arch. Intern. Med. 1997; 157: 1736-1744.
  41. Stoller J. K. Acute exacerbation of chronic obstructive lung disease. N. Engl. J. Med. 2002; 346: 988-993.
  42. Wedzicha J. A. Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease. Thorax 2000; 55 (suppl. 1): S23-S27.
  43. Niewoehner D. E., Erbland M. L., Deupree R. H. et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N. Eng. J. Med. 1999; 340: 1941-1947.
  44. Davies L., Angus R. M., Calverley P. M. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354: 456-460.
  45. Sunyer J., Saez M., Murillo С. et al. Air pollution and emergency room admission for chronic obstructive pulmonary disease: a 5-year study. Am. J. Epidemiol. 1993; 137: 701-705.
  46. Aaron S. D., Vandemheen K. L., Hebert P. et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med. 2003; 348: 2618- 2625.
  47. Fagon J. Y. Faut-il utiliser des corticoides au cours de rinsuffisance respiratoire aigue des insuffisances respiratoires chroniques obstructive? Rean. Urg. 1998; 7 (suppl. 1): 32-34.
  48. Shale D. Nebulised budesonide therapy in ICU. Care Crit. 111. 1996; 12: 15-17.
  49. Maliais F., Ostinelli J., Bourbeau J. et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2002; 165: 698-703.
  50. Авдеев С. H., Суточникова О. А., Белевский А. С., Чучалин А. Г. Применение небулизированного будесонида при тяжелом обострении хронической обструктивной болезни легких. Рандомизированное контролируемое исследование. Пульмонология 2003; 5: 81-88.
  51. Ewig S., Rodriguez-Roisin R., Torres A. Indications for and cjhoice of antibiotics in COPD. In: Similowski Т., Whitelaw W. A., Derenne J.-P., eds. L Clinical management of chronic obstructive pulmonary disease. New York: Marcel Dekker Inc.; 2002. 427-449.
  52. Sohy C., Pilette C., Niederman M. S., Sibille Y. Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Eur. Respir. J. 2002; 19: 966- 975.
  53. Anthonisen N. R., Manfreda J., Warren С. Р. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196-204.
  54. Ball P., Harris J. M., Lowson D. et al. Acute infective exacerbations of chronic bronchitis. Quart. J. Med. 1995; 88: 61-68. Societe de pathologie infectieuse de la langue francaise (SPILF). Revision de la IVe Conference de consensus en therapeutique anti-infectieuse de la SPILF. Rev. Mai. Respir. 2001; 18: 337-350.
  55. Campbell E. J. M. The J. Burns Amberson Lecture: the management of acute respiratory failure in chronic bronchitis and emphysema. Am. Rev. Respir. Dis. 1967; 96: 626-639.
  56. Bone R. C., Pierce A. K., Johnson R. L. Jr. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: a reappraisal. Am. J. Med. 1978; 65: 896-902.
  57. Mehta S., Hill N. S. Noninvasive ventilation. Am. J. Respir. Crit. Care Med. 2001; 163: 540-577.
  58. Meduri G. U., Conoscenti С. С., Menashe P., Nair S. Noninvasive fase mask ventilation in patients with acute respiratory failure. Chest 1989; 95: 865-870.
  59. Авдеев С. Н., Чучалин А. Г. Неинвазивная вентиляция легких при острой дыхательной недостаточности у больных
  60. Lightowler V. J., Wedzicha J. A., Elliott M. W., Ram F. S. F. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Br. Med. J. 2003; 326: 185.
  61. Brochard L., Mancebo J., Wysocki M. et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 1995; 333: 817-822.
  62. Kramer N., Meyer T. J., Meharg J. et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am. J. Respir. Crit. Care Med. 1995; 151: 1799-1806.
  63. Авдеев С. Н., Третьяков А. В., Григорьянц Р. А. и др. Исследование применения неинвазивной вентиляции легких при острой дыхательной недостаточности на фоне обострения хронического обструктивного заболевания легких. Анестезиол. и реаниматол. 1998; 3: 45-51.
  64. Avdeev S., Kutsenko М., Tretyakov A. et al. Posthospital survival in COPD patients after noninvasive positive pressure ventilation (NIPPV). Eur. Respir. J. 1998; 11: 312s.
  65. Bardi G., Pierotello R., Desideri M. et al. Nasal ventilation in COPD exacerbations', early and late results of a prospective, controlled study. Eur. Respir. J. 2000; 15: 98-104.
  66. Laghi F., D 'Alfonso N., Tobin M. J. Pattern of recovery from diaphragmatic fatigue over 24 hours. J. Appl. Physiol. 1995; 79: 539-546.
  67. Esteban A., Anzueto A., Alha I. et al. for the Mechanical Ventilation International Study Group. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am. J. Respir. Crit. Care Med. 2000; 161: 1450-1458.
  68. Come S., Gillespie D., Roberts D., Younes M. Effect of inspiratory flow rate on respiratory rate in intubated ventilated patients. Am. J. Respir. Crit. Care Med. 1997; 156: 304-308.
  69. Slutsky A. S. Mechanical ventilation. American College of Chest Physicians Consensus Conference. Chest 1993; 104: 1833-1859.
  70. Gladwin M. Т., Pierson D. J. Mechanical ventilation of the patient with severe chronic obstructive pulmonary disease. Intensive Care Med. 1998; 24: 898-910.
  71. Ranieri V. M., Giuliani R., Cinnella G. et al. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am. Rev. Respir. Dis. 1993; 147: 5-13.
  72. Fagon J. Y., Chastre J., Gibert C. Acute respiratory failure in chronic obstructive pulmonary disease. Bacterial infection as a precipitating factor. In: Dererme J.-P., Whitelaw W. A., Similowski Т., eds. Acute respiratory failure. New York: Marcel Dekker Inc.; 1995. 337-389.
  73. Brochard L., Rauss A., Benito S. et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am. J. Respir. Crit. Care Med. 1994; 150: 896-903.
  74. Esteban A., Alia I., Gordo F. et al. Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group.Am. J. Respir. Crit. Care Med. 1997; 156: 459-465.
  75. Nava S., Ambrosino N., Clini E. et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann. Intern. Med. 1998; 128: 721-728.
  76. Cremona G., Higenbottam T. Is there a place for vasodilators in stable COPD? In: Similowski Т., Whitelaw W. A., Dererme J.- P. eds. Clinical management of stable COPD. New York: Marcel Dekker Inc.; 2002. 359-382.
  77. Peinado V., Santos S., Ramirez J. et al. Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study. Eur. Respir. J. 2002; 20: 332-338.
  78. Hart С. М. Nitric oxide in adult lung disease. Chest 1999; 115: 1407-1417.
  79. Авдеев С. Н., Царева Н. А., Неклюдова Г. В., Чучалин А. Г. Ингаляционный оксид азота при легочной гипертензии у больных с обострением ХОБЛ. Сердеч. недостат. 2003; 5: 251-255.
  80. Faisy С., Diehl J.-L., Guerot E. et al. Utilisation du melange helium-oxygene en pratique pneumologique. Rev. J. Mai. Respir. 1999; 16: 1063-1073.
  81. Шогенова Л. В., Авдеев С. Н., Годяев М. Я., Чучалин А. Г. Эффекты гелий-кислородной смеси на гемодинамику, газообмен и транспорт кислорода у больных с гиперкапнической ОДН. В кн.: Тезисы 12-го Национального конгресса по болезням органов дыхания: Сборник резюме. М.; 2002. 125.
  82. Gerbaux P., Gainnier M., Boussuges A., et al. Use of heliox in patients with severe exacerbation of chronic obstructive pulmonary disease. Crit. Care Med. 2001; 29: 2322-2324.
  83. Jolliet P., Tassaux D., Thouret J. M. et al. Beneficial effects of helium: oxygen vs. air: oxygen noninvasive pressure support in with decompensated chronic obstructive pulmonary disease. Crit. Care Med. 1999; 27: 2422-2429.
  84. Jaber S., Fodil R., Carlucci A. et al. Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 161: 1191-1200.
  85. Samama M. M., Cohen А. Т., Darmon J.-Y. et al. A comparison of enoxaparin with placebo for the treatment of venous thromboembolism in acutely ill medical patients. N. Eng. J. Med. 1999; 341: 793-800.
  86. Fraisse F., Holzapfel L., Coulaud J.-M. et al. and The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am. J. Respir. Crit. Care Med. 2000; 161: 1109-1114.
  87. Kleber F.-X., Witt C., Vogel G. et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am. Heart J. 2003; 145: 614-621.
  88. Bellone A., Lascioli R., Raschi S. et al. Chest physical therapy in patients with acute exacerbation of chronic bronchitis: effectiveness of three methods. Arch. Phys. Med. Rehabil. 2000; 81: 558-560.
  89. American Thoracic Society Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: S77-S120.
  90. Societe de Pneumologie de Langue Francaise. Recommandations pour la prise en charge de la BPCO. Actualisation 2003 Argumentaire. Exacerbations/decompensations: diagnostic, niveaux de gravite et prise en charge (hors antibiotherapie). Rev. Mai. Respir. 2003; 20: 4S56-4S64.
  91. Chronic Obstructive Pulmonary Disease: National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59 (suppl.): 1-232.
  92. Bone R. C., Fuchs H., Fox N. L. et al. The chronic obstructive pulmonary disease mortality endpoint trial. Chest 1995; 108 (suppl.): R.
  93. Bardsley P. A., Tweney J., Morgan N., Howard P. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease. Thorax 1991; 46: 493-498.
  94. Greenstone M. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: Cochrane Library. Oxford: Update Software, 2002; issue 4.
  95. Angus R. M., Ahmed A. A., Fenwick L. J., Peacock A. J. Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease. Thorax 1996; 51: 1048-1050.
  96. Plant P. K., Elliott M. W. Chronic obstructive pulmonary disease. Management of ventilatory failure in COPD. Thorax 2003; 58: 537-542.
  97. Groenewegen K. H., Schols A. M., Wouters E. F. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467.
  98. Weiss S. M., Hudson L. D. Outcome from respiratory failure. Crit. Care Clin. 1994; 10: 197-215.
  99. Seneff M. G., Wagner D. P., Wagner R. P. et al. Hospital and 1 -year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. J. A. M. A. 1995; 274: 1852-1857.
  100. Fuso L., Incalzi R. A., Pistelli R. et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstruc tive pulmonary disease. Am. J. Med. 1995; 98: 272-277.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2004 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies